Literature DB >> 9458812

Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures.

M Rüdiger1, I Kolleck, G Putz, R R Wauer, P Stevens, B Rüstow.   

Abstract

The alkenyl-acyl subclass of phosphatidylethanolamine (PtdEtn) and phosphatidylcholine (plasmalogens) are minor components of alveolar surfactant. Plasmalogens promote and stabilize hexagonal structures of phospholipids. In another study (W.R. Perkins, R.B. Dause, R.A. Parente, S.R. Michey, K.C. Neuman, S.M. Gruner, T.F. Taraschi, and A.S. Janoff. Science 273: 330-332, 1996), it was shown that polymorphic phase behavior may have an important role in the effective functioning of pulmonary surfactant. Therefore, we hypothesized that surface properties of phospholipid mixtures that contain plasmalogens are superior to plasmalogen-free mixtures. The effect of plasmalogens on surface tension of surfactant-like phospholipid mixtures (70 mol% dipalmitoyl phosphatidylcholine, 10 mol% phosphatidylglycerol, and 20 mol% PtdEtn) was measured. Using the pulsating bubble surfactometer, we show that an increasing amount of ethanolamine plasmalogens [plasmenylethanolamine (PlsEtn) results in reduction of surface tension (0 mol% PlsEtn 44.7 +/- 1.7, 2 mol% 33.5 +/- 1.7, 4 mol% 36 +/- 3.1, 6 mol% 26.2 +/- 2.9, and 8 mol% 22.2 +/- 0.3 mN/m). By means of the captive bubble surfactometer, minimal surface tension reached with 8 mol% PlsEtn was even lower (3.8 +/- 0.7 mN/m). With regard to morphological studies (B. Fringes, K. Gorgas, and A. Reith. Eur. J. Cell Biol. 46: 136-143, 1988), clofibrate treatment of rats might increase the plasmalogen content of alveolar surfactant. However, in the present study, we could not show that synthesis and secretion of plasmalogens are affected by clofibrate treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458812     DOI: 10.1152/ajplung.1998.274.1.L143

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Evidence that plasmalogen is protective against oxidative stress in the rat brain.

Authors:  Beth Kuczynski; Nicholas V Reo
Journal:  Neurochem Res       Date:  2006-05-24       Impact factor: 3.996

Review 2.  Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.

Authors:  Smeeta Sardesai; Manoj Biniwale; Fiona Wertheimer; Arlene Garingo; Rangasamy Ramanathan
Journal:  Pediatr Res       Date:  2016-10-05       Impact factor: 3.756

3.  The YhhN protein of Legionella pneumophila is a Lysoplasmalogenase.

Authors:  Marianne S Jurkowitz; Aalapi Patel; Lai-Chu Wu; Annalise Krautwater; Douglas R Pfeiffer; Charles E Bell
Journal:  Biochim Biophys Acta       Date:  2014-11-16

4.  Peroxisomes in mouse and human lung: their involvement in pulmonary lipid metabolism.

Authors:  Srikanth Karnati; Eveline Baumgart-Vogt
Journal:  Histochem Cell Biol       Date:  2008-07-30       Impact factor: 4.304

5.  Influence of surfactant protein C on the interfacial behavior of phosphatidylethanolamine monolayers.

Authors:  Albena Jordanova; Georgi As Georgiev; Svobodan Alexandrov; Roumen Todorov; Zdravko Lalchev
Journal:  Eur Biophys J       Date:  2008-11-01       Impact factor: 1.733

6.  Low-concentration ozone reacts with plasmalogen glycerophosphoethanolamine lipids in lung surfactant.

Authors:  Kelly M Wynalda; Robert C Murphy
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

Review 7.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

8.  Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.

Authors:  Rui Wang-Sattler; Yao Yu; Kirstin Mittelstrass; Eva Lattka; Elisabeth Altmaier; Christian Gieger; Karl H Ladwig; Norbert Dahmen; Klaus M Weinberger; Pei Hao; Lei Liu; Yixue Li; H-Erich Wichmann; Jerzy Adamski; Karsten Suhre; Thomas Illig
Journal:  PLoS One       Date:  2008-12-05       Impact factor: 3.240

9.  The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure.

Authors:  Carsten Schleh; Christian Mühlfeld; Karin Pulskamp; Andreas Schmiedl; Matthias Nassimi; Hans D Lauenstein; Armin Braun; Norbert Krug; Veit J Erpenbeck; Jens M Hohlfeld
Journal:  Respir Res       Date:  2009-09-30

10.  Persurf, a new method to improve surfactant delivery: a study in surfactant depleted rats.

Authors:  Wolfram Burkhardt; Stephan Kraft; Matthias Ochs; Hans Proquitté; Lars Mense; Mario Rüdiger
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.